Report

Unilateral Sulcus Implantation of the Crystalens HD

Ioannis G. Pallikaris, MD, PhD; Alexandra E. Karavitaki, MD; George D. Kymionis, MD, PhD; Georgios A. Kontadakis, MD, MSc; Sophia I. Panagopoulou, PhD; George A. Kounis, PhD

  • Journal of Refractive Surgery
  • April 2012 - Volume 28 · Issue 4: 299-301
  • DOI: 10.3928/1081597X-20120127-01
Rights and Permissions

Abstract

PURPOSE:

To evaluate the results after unilateral sulcus implantation of the Crystalens HD (Bausch & Lomb) accommodative intraocular lens (IOL).

METHODS:

This retrospective interventional case series comprised six eyes from three patients who underwent cataract surgery and bilateral Crystalens HD accommodative IOL implantation. The Crystalens HD was implanted in the bag in one eye (non-sulcus group) and, due to posterior capsule rupture, the lens was positioned in the ciliary sulcus in the fellow eye (sulcus group).

RESULTS:

Mean patient age was 66.3±4.9 years (range: 60 to 72 years). Mean follow-up was 14.3±3.2 months (range: 12 to 18 months) for the non-sulcus group and 14±2 months (range: 12 to 16 months) for the sulcus group. Uncorrected distance visual acuity improved from 20/100 to 20/33 in the non-sulcus group and from 20/63 to 20/32 in the sulcus group during last follow-up. Corrected distance visual acuity improved from 20/35 to 20/20 in the non-sulcus group and from 20/27 to 20/23 in the sulcus group. Regarding near vision, all eyes in the sulcus group and 66.7% of eyes in the non-sulcus group achieved J1–J2 (Birkhauser reading chart). None of the eyes had any intra- (except posterior capsule rupture in the sulcus cases) or postoperative complications.

CONCLUSIONS:

Based on this small series, ciliary sulcus implantation of the Crystalens HD seems to be associated with no significant morbidity and provides satisfactory visual acuity outcomes.

AUTHORS

From the Institute of Vision and Optics, University of Crete, Crete, Greece.

The authors have no financial or proprietary interests in the materials presented herein.

Drs Pallikaris and Karavitaki contributed equally to this work.

Correspondence: Alexandra E. Karavitaki, MD, Institute of Vision and Optics, University of Crete, Medical School, 71003 Heraklion, Crete, Greece. Tel: 30 2810 371800; Fax: 30 2810 394653; E-mail: karavalexmed@hotmail.com

Received: June 28, 2011
Accepted: November 28, 2011
Posted Online: February 01, 2012

doi: 10.3928/1081597X-20120127-01

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.

[X]